STRO

Sutro Biopharma, Inc.NASDAQHealthcare

$23.78-4.38%ClosedMarket Cap: $202.1M

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-25	Deutsche Bank	—	Buy	—
2026-03-24	HC Wainwright & Co.	—	Buy	—
2026-03-24	Wells Fargo	—	Overweight	—
2026-01-20	Citizens	—	Market Outperform	—
2025-12-22	HC Wainwright & Co.	—	Neutral	—
2025-08-12	Wells Fargo	—	Equal Weight	—
2025-06-16	Piper Sandler	—	Overweight	—
2025-05-19	B of A Securities	—	Underperform	—
2025-04-29	HC Wainwright & Co.	—	Neutral	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$-8.65	$21.1M	5
Sun Dec 31	$-7.93	$38.2M	6
Mon Dec 31	$-7.44	$55.0M	4
Tue Dec 31	$-6.12	$70.9M	2